KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Capital Leases (2016 - 2018)

Historic Capital Leases for Medpace Holdings (MEDP) over the last 4 years, with Q4 2018 value amounting to $24.5 million.

  • Medpace Holdings' Capital Leases fell 796.18% to $24.5 million in Q4 2018 from the same period last year, while for Dec 2018 it was $24.5 million, marking a year-over-year decrease of 796.18%. This contributed to the annual value of $24.5 million for FY2018, which is 796.18% down from last year.
  • According to the latest figures from Q4 2018, Medpace Holdings' Capital Leases is $24.5 million, which was down 796.18% from $25.0 million recorded in Q3 2018.
  • Medpace Holdings' Capital Leases' 5-year high stood at $30.3 million during Q4 2015, with a 5-year trough of $24.5 million in Q4 2018.
  • In the last 4 years, Medpace Holdings' Capital Leases had a median value of $27.1 million in 2017 and averaged $27.1 million.
  • In the last 5 years, Medpace Holdings' Capital Leases crashed by 576.75% in 2016 and then crashed by 796.18% in 2018.
  • Medpace Holdings' Capital Leases (Quarter) stood at $30.3 million in 2015, then decreased by 5.77% to $28.5 million in 2016, then dropped by 6.75% to $26.6 million in 2017, then decreased by 7.96% to $24.5 million in 2018.
  • Its Capital Leases was $24.5 million in Q4 2018, compared to $25.0 million in Q3 2018 and $25.6 million in Q2 2018.